Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024;77(4):641-648.
doi: 10.5173/ceju.2024.0210. Epub 2024 Nov 16.

Benzodiazepines use and dependence in female patients with overactive bladder symptoms - prevalence and clinical correlations

Artur Rogowski  1 , Maria Krowicka-Wasyl  2 , Bartosz Dybowski  3 , Halina Sienkiewicz-Jarosz  4 , Adam Wichniak  5 , Jerzy Samochowiec  6 , Marcin Wojnar  7 , Tadeusz Issat  2 , Tomasz Syrylo  8 , Katarzyna Jankiewicz  9 , Przemysław Bieńkowski  7
Affiliations

Benzodiazepines use and dependence in female patients with overactive bladder symptoms - prevalence and clinical correlations

Artur Rogowski et al. Cent European J Urol. 2024.

Abstract

Introduction: GABAergic sedative-hypnotics, including benzodiazepines (BDZs) and Z-drugs, are some of the most used and misused psychotropic medications in developed countries. Growing evidence points to the role of psychiatric comorbidities in overactive bladder (OAB) and in urge urinary incontinence. The aim of the present study was to evaluate: 1) the prevalence of BDZs and/or Z-drugs use in female OAB patients, 2) the risk of dependence on BDZs and/or Z-drugs in female OAB patients, 3) the relationship between the use of BDZs and/or Z-drugs and the severity of OAB symptoms.

Material and methods: The prevalence of BDZs and/or Z-drugs use, the risk of dependence on BDZs and/or Z-drugs, and the relationship between the use of BDZs and/or Z-drugs and the severity of OAB symptoms was assessed in OAB patients recruited in the urogynecological outpatient clinic.

Results: A higher percentage of OAB patients confirmed the use of GABAergic sedative-hypnotics in the last 12 months as compared to the non-OAB outpatients presenting for routine gynecological prophylaxis. A larger number of OAB patients (5.6%) met the diagnosis of lifetime BDZ (and/or Z-drug) dependence as compared to the controls (0.9%). The use of sedative-hypnotics did not correlate with OAB symptoms.

Conclusions: Our results suggest that the use of and dependence on GABAergic sedative-hypnotics may be associated with the OAB diagnosis in female urogynecological patients.

Keywords: Z-drugs; benzodiazepines; dependence; overactive bladder; urinary incontinence; urogynecology; use.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

See all similar articles

References

    1. Zaami S, Graziano S, Tittarelli R, Beck R, Marinelli E. BDZs, Designer BDZs and Z-drugs: pharmacology and misuse insights. Curr Pharm Des. 2022; 28: 1221–1229. - PubMed
    1. Soni A, Thiyagarajan A, Reeve J. Feasibility and effectiveness of deprescribing benzodiazepines and Z-drugs: systematic review and meta-analysis. Addiction. 2023; 118: 7–16. - PubMed
    1. Wichniak A, Bieńkowski P, Dudek D, et al. . Letter to Editor. Position of the Polish Psychiatric Association on the use of benzodiazepine derivatives and drugs with a similar mechanism of action in the treatment of mental disorders. Psychiatr Pol. 2023; 57: 873–875. - PubMed
    1. Schatzberg AF, Nemeroff ChB. The American Psychiatric Association Publishing Textbook of Psychopharmacology, Fifth Edition. American Psychiatric Publishing 2017.
    1. Peron EP, Gray SL, Hanlon JT. Medication use and functional status decline in older adults: a narrative review. Am J Geriatr Pharmacother. 2011; 9: 378–391. - PMC - PubMed

LinkOut - more resources